NCT03456297 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Wu XV, Chan YS, Tan KHS, Wang W
A systematic review of online learning programs for nurse preceptors. Nurse Educ Today. 2018 Jan;60:11-22. doi: 10.1016/j.nedt.2017.09.010. Epub 2017 Sep 28.
Wu XV, Enskar K, Heng DG, Pua LH, Wang W
The perspectives of preceptors regarding clinical assessment for undergraduate nursing students. Int Nurs Rev. 2016 Sep;63(3):473-81. doi: 10.1111/inr.12272. Epub 2016 Apr 21.
Wu XV, Enskar K, Pua LH, Heng DGN, Wang W
Clinical nurse leaders' and academics' perspectives in clinical assessment of final-year nursing students: A qualitative study. Nurs Health Sci. 2017 Sep;19(3):287-293. doi: 10.1111/nhs.12342. Epub 2017 Mar 30.
Wu XV, Wang W, Pua LH, Heng DG, Enskar K
Undergraduate nursing students' perspectives on clinical assessment at transition to practice. Contemp Nurse. 2015 Oct-Dec;51(2-3):272-85. doi: 10.1080/10376178.2016.1163232. Epub 2016 Mar 30.

Web-based Clinical Pedagogy Program to Enhance Nurse Preceptors' Teaching Competency and Nursing Students' Learning Outcomes in Clinical Competency

Clinical trial NCT03456297 - References